Spanning the connected health ecosystem seeking to effect policy changes
CHI is a not-for-profit multistakeholder policy and legal advocacy coalition driven by a consensus of stakeholders from across the connected health ecosystem which aims to realize an environment where Americans can improve their health using digital and connected health technologies to enhance health outcomes and reduce costs equitably.
03/18/2025- Comments of the Connected Health Initiative in Response to the Drug Enforcement Agency’s Requests for Input, Special Registrations for Telemedicine, and Limited State Telemedicine Registrations
03/07/2025- Comments of the Connected Health Initiative, HIPAA Security Rule To Strengthen the Cybersecurity of Electronic Protected Health Information [HHS-OCR-2024-30983; 90 FR 898]
01/27/2025- Comments of the Connected Health Initiative Regarding Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts (89 FR 93545)
01/27/2025- Connected Health Initiative Comments to the Centers for Medicare & Medicaid Services’ Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly [CMS- 4208-P; 89 FR 99340]
01/15/2025- Connected Health Initiative’s Recommendations to the Center for Medicare and Medicaid Services for the 2026 Medicare Physician Fee Schedule
11/29/2024- Connected Health Initiative’s Comments on the Proposed Rule Regarding Access to Americans’ Bulk Sensitive Data and Government-Related Data by Countries of Concern
10/04/2024- Connected Health Initiative Comments on the Food and Drug Administration Center for Devices and Radiological Health Discussion Paper: Health Equity for Medical Devices [Docket No. FDA-2024-N-3616]
10/04/2024- Comments of the Connected Health Initiative to the Office of the National Coordinator for Health Information Technology on Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (89 FR 63498)
09/26/2024- Connected Health Initiative Comments on the Food and Drug Administration’s Draft Guidance for Industry on “Diversity Action Plans to Improve Enrollment of Participants From Underrepresented Populations in Clinical Studies” [Docket No. FDA-2021-D-0789]
09/20/2024- Connected Health Initiative Response to Department of Justice and Federal Trade Commission’s Request for Information for Public Comment on Corporate Consolidation Through Serial Acquisitions and Roll-up Strategies
09/09/2024- Connected Health Initiative Comments on the Center for Medicare and Medicaid Services Medicare and Medicaid Programs: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs, including the Hospital Inpatient Quality Reporting Program; Health and Safety Standards for Obstetrical Services in Hospitals and Critical Access Hospitals; Prior Authorization; Requests for Information; Medicaid and CHIP Continuous Eligibility; Medicaid Clinic Services Four Walls Exceptions; Individuals Currently or Formerly in Custody of Penal Authorities; Revision to Medicare Special Enrollment Period for Formerly Incarcerated Individuals; and All-Inclusive Rate Add-On Payment for High-Cost Drugs Provided by Indian Health Service and Tribal Facilities (CMS-1809-P; 89 FR 59186)
08/26/2024- Comments of the Connected Health Initiative to the Centers for Medicare & Medicaid Services on Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies (CMS-1803-P; 89 FR 55312)
7/26/2024- Letter on the Importance of Medical Innovation
7/18/2024- Comments of the Connected Health Initiative, Input on Certain Non-Device Software Functions and Impacts to Patient Safety (Docket No. FDA-2018-N-1910)
07/03/2024-Comments of the Connected Health Initiative, Cyber Incident Reporting for Critical Infrastructure Act (CIRCIA) Reporting Requirements (89 FR 23644)
06/10/2024- CHI Comments to the Centers for Medicare & Medicaid Services and Hospital IPPS Rules for 2025
06/05/2024 – CHI Response to the Department of Justice, Department of Health and Human Services, and Federal Trade Commission’s Request for Information on Consolidation in Health Care
05/29/2024- CHI Comments to the Centers for Medicare & Medicaid Services on Medicare Program; Request for Information on Medicare Advantage Data
05/28/2024- Connected Health Initiative Comments on the Draft 2024-2030 Federal Health IT Strategic Plan
05/24/2024- State of Artificial Intelligence in Healthcare
05/13/2024- CHI Comments regarding Draft Guidance for Industry and Food and Drug Administration Staff, Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the Federal Food, Drug, and Cosmetic Act
05/03/2024- Connected Health Initiative Input on the Health Over Wealth Act
05/02/2024- Connected Health Initiative Comments on the International Medical Device Regulators Forum’s Proposed Document, ‘Medical Device Software: Considerations for Device and Risk Characterization’
03/16/2024- Connected Health Initiative Comments Re Centers for Medicare & Medicaid Services 2nd Medicare Prescription Payment Plan Guidelines
03/10/2024- FSMB Ethics and Professionalism Committee Report: Guidelines and Recommendations to Aid State Medical Boards and Physicians in Navigating the Responsible and Ethical Incorporation of AI into Clinical Practice
02/29/2024- Connected Health Initiative Comments to the Food and Drug Administration’s Request for Comments on Digital Health Technologies for Detecting Prediabetes and Undiagnosed Type 2 Diabetes
02/14/2024- CHI Pre-Draft 2025 Physician Fee Schedule Recommendations to CMS
02/02/2024- Comments of the Connected Health Initiative regarding Solicitation of Proposals for New and Modified Safe Harbors and Special Fraud Alerts
01/02/2024- Comments of the Connected Health Initiative to the Centers for Medicare & Medicaid Services (CMS) and Office of the National Coordinator for Health Information Technology (ONC) on 21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking (HHS-ONC-2023-0007; 88 FR 23746)
9/11/2023–Connected Health Initiative Comments on the Center for Medicare and Medicaid Services’ Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; Quality Reporting Programs; Payment for Intensive Outpatient Services in Rural Health Clinics, Federally Qualified Health Centers, and Opioid Treatment Programs; Hospital Price Transparency; Changes to Community Mental
Health Centers Conditions of Participation, Proposed Changes to the Inpatient Prospective Payment System Medicare Code Editor; Rural Emergency Hospital Conditions of Participation Technical Correction (CMS-1786-P; 88 FR 49552)
8/28/2023-Comments to the Centers for Medicare and Medicaid Services’ Medicare and Medicaid Programs; CY 2024 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; Medicare Advantage; Medicare and Medicaid Provider and Supplier Enrollment Policies;and Basic Health Program [CMS-1784-P; 88 FR 52262]
8/28/2023-Connected Health Initiative Comments on the Center for Medicare and Medicaid Services’ Medicare Program; Transitional Coverage for Emerging Technologies
(88 Fed Reg 41633; CMS-3421-NC)
8/25/2023-Multi–stakeholder Comments to the Centers for Medicare and Medicaid Services re: Medicare and Medicaid Programs: Calendar Year 2024 Payment Policies under the Physician Fee Schedule and Other Changes to Part B Payment Policies, etc. (CMS–1784–P)
7/7/2023–Comments of the Connected Health Initiative to the White House’s Office of Science and Technology Policy on Request for Information; National
Priorities for Artificial Intelligence (88 FR 34194; OSTP-TECH-2023-0007)
